http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d75400a670a87ba365425c1ebe61f8f3
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Grivas |
| name | Petros Grivas |
| given-name | Petros |
| organization-name | 6Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington. University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Fred Hutchinson Cancer Research Center; University of Washington; Seattle Cancer Care Alliance Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington (Petros Grivas), USA. Division of Medical Oncology University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, WA Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio aDepartment of Medicine, Division of Oncology, University of Washington, and; bClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Departments of Hematology-Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA University of Washington Seattle Washington 13Department of Oncology, University of Washington, Seattle, Washington. Department of Medicine, Division of Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington, USA Division of Oncology, Department of Medicine, University of Washington, Seattle, WA Department of Medicine, Division of Medical Oncology, University of Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA. Fred Hutchinson Cancer Research Center Seattle University of Washington Seattle WA USA Division of Medical Oncology Clinical Research Division Department of Medicine Fred Hutchinson Cancer Research Center University of Washington Seattle WA USA Department of Medicine, Division of Medical Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio Fred Hutchinson Cancer Center, Division of Medical Oncology, Department of Medicine, University of Washington Medicine, Seattle Department of Medicine, Division of Oncology, University of Washington, Seattle, Washington. Fred Hutchinson Cancer Research Center, Seattle, Washington. All authors: Cleveland Clinic Taussig Cancer Institute, Cleveland, OH. University of Washington, Seattle, Washington Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA 1Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio.; 10University of Washington, Department of Medicine, Division of Oncology, Seattle, Washington. Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA; University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA University of Washington, Fred Hutchinson Cancer Center , Seattle, WA , USA Division of Medical Oncology, University of Washington, Seattle, WA, USA; Division of Medical Oncology, Seattle Cancer Care Alliance, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Department of Medicine, Division of Medical Oncology, University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Medicine, Division of Medical Oncology, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, 1144 Eastlake Ave, E. LG-465, Seattle, WA 98109, USA University of Washington, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle Cleveland Clinic, Cleveland, OH, USA Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH Department of Medicine, Division of Medical Oncology, University of Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98109-1023, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109-1023, USA Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA; Clinical Research Division, Fred Hutchison Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington, USA Fred Hutchinson Cancer Research Center Seattle Washington USA; Division of Medical Oncology, Department of Medicine University of Washington Seattle Washington USA Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington for the COVID-19 and Cancer Consortium University of Washington and Fred Hutchinson Cancer Center Seattle Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, University of Washington, Seattle Meena Sadaps, Pauline Funchain, Haider Mahdi, Amy Pritchard, Stefan Klek, Bassam Estfan, Jame Abraham, G. Thomas Budd, James P. Stevenson, Nathan A. Pennell, Alok A. Khorana, Brian J. Bolwell, and Davendra P.S. Sohal, Cleveland Clinic, Cleveland, OH; and Petros Grivas, University of Washington Medical Center, Seattle, WA. Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington, Seattle, WA 98195, USA Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. Genitourinary Cancers Program Fred Hutchinson Cancer Research Center University of Washington Seattle WA USA Fred Hutchinson Cancer Research Center, University of Washington; Seattle Cancer Care Alliance, Seattle, WA 98109, USA Department of Medicine, Division of Medical Oncology, University of Washington, Seattle; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington Department of Medicine Division of Oncology University of Washington School of Medicine and Fred Hutchinson Cancer Research Center Seattle WA USA; Department of Hematology and Medical Oncology Taussig Cancer Institute Cleveland Clinic Cleveland OH USA Division of Oncology, Department of Medicine University of Washington Seattle Washington USA; Clinical Research Division, Fred Hutchinson Cancer Research Center Seattle Washington USA Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Medicine, Division of Oncology, University of Washington, Seattle, WA, USA for the COVID-19 and Cancer Consortium (CCC19) Department of Hematology/Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA Cleveland Clinic, Cleveland OH University of Washington Seattle Cancer Care Alliance Fred Hutchinson Cancer Research Center Seattle WA USA Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington Division of Medical Oncology Department of Medicine University of Washington Seattle WA USA; Clinical Research Division Fred Hutchinson Cancer Research Center Seattle WA USA 6Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington; and Division of Oncology, Department of Medicine, University of Washington Fred Hutchinson Cancer Research Center Seattle Washington Seattle Cancer Care Alliance Seattle Washington; Department of Medicine, Division of Oncology University of Washington Seattle Washington; Fred Hutchinson Cancer Research Center Seattle Washington University of Washington, Seattle, WA Department of Hematology and Medical Oncology Taussig Cancer Institute, Cleveland Clinic Cleveland Ohio Fred Hutchinson Cancer Center, University of Washington , Seattle, WA , USA University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington, USA. Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA; Current address: University of Washington, Seattle, WA, USA From the University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA Division of Oncology, Department of Medicine, University of Washington, Seattle; Fred Hutchinson Cancer Center, Seattle, Washington Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA From Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St. Bartholomew’s Hospital, London (T.P.); Sungkyunkwan University Samsung Medical Center, Seoul, South Korea (S.H.P.); Centre Jean Bernard Clinique Victor Hugo, Le Mans (E.V.), and Gustave Roussy, INSERM Unité 981, Université Paris-Saclay, Villejuif (Y.L.) — both in France; the Medical Oncology Unit, Azienda Ospedaliera S. Maria, Terni (C.C.), and Pfizer, Milan (C.F., A.P.) — both in Italy; the Department... |
Incoming Links
Total number of triples: 253.